H
Heinz Jakob
Researcher at University of Duisburg-Essen
Publications - 354
Citations - 12258
Heinz Jakob is an academic researcher from University of Duisburg-Essen. The author has contributed to research in topics: Aortic dissection & Aortic valve. The author has an hindex of 54, co-authored 350 publications receiving 10806 citations.
Papers
More filters
Journal ArticleDOI
Is universal antifungal prophylaxis mandatory in adults after lung transplantation? A review and meta-analysis of observational studies.
Kevin Pilarczyk,Nils Haake,J. Heckmann,Henning Carstens,Assad Haneya,Jochen Cremer,Heinz Jakob,Nikolaus Pizanis,Markus Kamler +8 more
TL;DR: No randomized‐controlled trials (RCT) or international guidelines on antifungal prophylaxis (AFP) in the LTX population exist, but there are calls for more research into this issue.
Journal ArticleDOI
Diagnostic role and prognostic implications of D-dimer in different classes of acute aortic syndromes.
Riccardo Gorla,Riccardo Gorla,Raimund Erbel,Philipp Kahlert,Konstantinos Tsagakis,Heinz Jakob,A A Mahabadi,Thomas Schlosser,Holger Eggebrecht,Eduardo Bossone,Rolf Alexander Jánosi +10 more
TL;DR: D-d was a reliable diagnostic marker for AAD and IMH, but not for PAU, and at 3-year follow-up D-d levels did not affect survival.
Journal ArticleDOI
Angioscopy — a valuable tool in guiding hybrid stent grafting and decision making during type A aortic dissection surgery
TL;DR: Angioscopy has become an indispensable tool for decision making in AD to apply OVAC, downstream stent grafting and landing zone control with the ability to indicate ballooning at neglectable time requirements during HCA.
Journal ArticleDOI
The frozen elephant trunk treatment is the operation of choice for all kinds of arch disease.
Konstantinos Tsagakis,Daniel Wendt,Alexandros M Dimitriou,Matthias Thielmann,Sharaf-Eldin Shehada,Mohamed El Gabry,Heinz Jakob +6 more
TL;DR: FET is the surgical treatment option of choice to achieve lasting results down to the stent-graft end for all comers with all kinds of arch disease and facilitates additional endovascular or surgical treatment downstream, if required.
Journal ArticleDOI
Management of High-Risk Patients With Aortic Stenosis and Coronary Artery Disease
Daniel Wendt,Philipp Kahlert,Tim Lenze,Markus Neuhäuser,Vivien Price,Thomas Konorza,Raimund Erbel,Heinz Jakob,Matthias Thielmann +8 more
TL;DR: The present study demonstrates that transcatheter aortic valve implantation in combination with prior percutaneous coronary intervention within 12 months produces similar results in a propensity score matched high-risk patient population.